Saroja Pharma Industries India Limited — Others, 31-03-2025: Trading Window

Saroja Pharma Industries has announced a board meeting to review the financial results for the half-year and year ending 31st March 2025. The trading window for directors, designated persons, and their immediate relatives will be closed from 1st April 2025 until 48 hours after the results are declared. This closure is part of the company’s compliance with insider trading regulations. Investors should consider the temporary trading halt as a strategic move to ensure transparency and may view this as a standard procedural safeguard, maintaining a neutral outlook during this period.